The historical rank and industry rank for Hubei Jumpcan Pharmaceutical Co's FCF Margin % or its related term are showing as below:
SHSE:600566'
s FCF Margin % Range Over the Past 10 Years
Min: 7.84 Med: 21.75 Max: 32.75
Current: 17.3
During the past 13 years, the highest FCF Margin % of Hubei Jumpcan Pharmaceutical Co was 32.75%. The lowest was 7.84%. And the median was 21.75%.
SHSE:600566's FCF Margin % is ranked better than 85.25% of 956
companies
in the Drug Manufacturers industry
Industry Median: 2.48
vs SHSE:600566: 17.30
Hubei Jumpcan Pharmaceutical Co FCF Margin % Related Terms
Hubei Jumpcan Pharmaceutical Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hubei Jumpcan Pharmaceutical Co FCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Jumpcan Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hubei Jumpcan Pharmaceutical Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hubei Jumpcan Pharmaceutical Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Hubei Jumpcan Pharmaceutical Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hubei Jumpcan Pharmaceutical Co (SHSE:600566) has a FCF Margin % of 56.87% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hubei Jumpcan Pharmaceutical Co and its competitors. This is 161% above median its historical median of 21.75. Over the past decade, Hubei Jumpcan Pharmaceutical Co's FCF Margin % has ranged from 7.84 to 32.75. According to the industry distribution chart, Hubei Jumpcan Pharmaceutical Co ranks #141 out of 956 companies in the Drug Manufacturers industry, placing it in the top 14.7%.
Is Hubei Jumpcan Pharmaceutical Co's FCF Margin % too high?
Hubei Jumpcan Pharmaceutical Co's current FCF Margin % of 56.87% is 161% above median its 10-year median of 21.75. Over the past 10 years, this metric has ranged from a low of 7.84 to a high of 32.75. The Drug Manufacturers industry median FCF Margin % is 2.48. Hubei Jumpcan Pharmaceutical Co's value of 56.87% is 2193.1% above this industry median. Based on the distribution chart, Hubei Jumpcan Pharmaceutical Co ranks #141 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hubei Jumpcan Pharmaceutical Co has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hubei Jumpcan Pharmaceutical Co's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hubei Jumpcan Pharmaceutical Co ranks #141 out of 956 companies for FCF Margin %. This places Hubei Jumpcan Pharmaceutical Co in the top 15% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.48. Hubei Jumpcan Pharmaceutical Co's value of 56.87% is 2193.1% above this benchmark. Historically, Hubei Jumpcan Pharmaceutical Co's own FCF Margin % has ranged from 7.84 to 32.75 over the past decade. While the company's 10-year median is 21.75 vs. the industry median of 2.48, Hubei Jumpcan Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hubei Jumpcan Pharmaceutical Co's current FCF Margin % of 56.87% is 2193.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hubei Jumpcan Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hubei Jumpcan Pharmaceutical Co's current FCF Margin % is 56.87%, which is 161% above median its own 10-year median of 21.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hubei Jumpcan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hubei Jumpcan Pharmaceutical Co (SHSE:600566) is currently considered Fairly Valued. The stock's GF Value™ is ¥20.89, compared to a current price of ¥21.88 — trading 4.7% above its estimated fair value. The current FCF Margin % is 56.87%, which is 161% above median its 10-year median of 21.75 and 2193.1% above the Drug Manufacturers industry median of 2.48. Hubei Jumpcan Pharmaceutical Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Hubei Jumpcan Pharmaceutical Co (SHSE:600566), the current FCF Margin % is 56.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Overvalued in 2026?
Based on GuruFocus' analysis, Hubei Jumpcan Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥21.88 is trading 4.7% above its estimated GF Value™ of ¥20.89.
GuruFocus considers Hubei Jumpcan Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:600566:
FCF Margin %: 56.87% (161% above median its 10-year median of 21.75)
GF Value™: ¥20.89 vs. price of ¥21.88 (4.7% above fair value)
Industry Position: 2193.1% above the Drug Manufacturers median (#141 of 956)
No single metric tells the full story. See the SHSE:600566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hubei Jumpcan Pharmaceutical Co Business Description
Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemicals based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and Western medicines in the areas of pediatrics, gynecology, pneumonology, gastroenterology, and geriatrics. The company also develops Chinese and Western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.
86GF Score
Get the complete analysis for SHSE:600566
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600566 has been successfully added to your 
